Which drug is known to produce Stevens-Johnson syndrome in HIV-infected individuals?
Which drug is known to cause red cell aplasia?
What is the mechanism of action of Acyclovir?
Which antimalarial agent is safe for use in pregnancy?
What is the drug of choice for treating Strongyloides stercoralis infection?
Oral vancomycin is indicated for the treatment of which condition?
What is the primary treatment for tetanus?
All of the following cephalosporins have good activity against Pseudomonas aeruginosa except?
Which drug can be safely administered in a patient with G6PD deficiency?
What is the drug of choice for multidrug-resistant Staphylococcus aureus?
Explanation: **Explanation:** **Thioacetazone** is a bacteriostatic second-line anti-tubercular drug. The correct answer is C because Thioacetazone is notorious for causing severe, life-threatening cutaneous adverse drug reactions (CADR), specifically **Stevens-Johnson Syndrome (SJS)** and **Toxic Epidermal Necrolysis (TEN)**, in patients with HIV co-infection. The risk is significantly higher in this population due to altered immune responses and glutathione deficiency. Consequently, the WHO and national guidelines (including NTEP) strictly contraindicate the use of Thioacetazone in HIV-positive individuals. **Analysis of Incorrect Options:** * **A. Paraaminosalicylate (PAS):** Primarily causes gastrointestinal distress (nausea, vomiting, diarrhea) and hypersensitivity reactions like skin rashes or drug-induced hepatitis, but it is not specifically linked to SJS in HIV patients. * **B. Cycloserine:** Known for its **neuropsychiatric side effects** (the "psych-drug"), including seizures, psychosis, and depression. It does not typically cause severe cutaneous reactions. * **D. Rifampicin:** Commonly causes a harmless orange discoloration of body fluids (urine, sweat, tears) and hepatotoxicity. While it can cause "flu-like syndrome," it is not the primary culprit for SJS in the context of HIV. **High-Yield Clinical Pearls for NEET-PG:** * **Thioacetazone Rule:** Never prescribe Thioacetazone to a patient unless their HIV status is confirmed negative. * **Other SJS Culprits in HIV:** Apart from Thioacetazone, **Nevirapine** (an NNRTI) and **Sulfonamides** (like Cotrimoxazole) are the most common causes of SJS in HIV-infected individuals. * **Mechanism:** Thioacetazone inhibits mycolic acid synthesis (similar to Isoniazid) but is rarely used today due to its toxicity profile.
Explanation: **Explanation:** **Chloramphenicol** is a broad-spectrum antibiotic that inhibits the 50S ribosomal subunit. Its most significant and dreaded adverse effect is **bone marrow suppression**, which occurs in two distinct forms: 1. **Dose-dependent suppression:** A reversible reduction in erythropoiesis (leading to anemia, leukopenia, or thrombocytopenia) due to the inhibition of mitochondrial protein synthesis. 2. **Dose-independent (Idiosyncratic) Aplastic Anemia:** A rare but often fatal condition where the bone marrow fails to produce all three blood cell lines (pancytopenia). This includes **pure red cell aplasia**, where there is a selective failure of red blood cell production. **Analysis of Incorrect Options:** * **A. Aminoglycosides:** Primarily known for **ototoxicity** (vestibular and cochlear damage) and **nephrotoxicity** (acute tubular necrosis). They do not typically affect the bone marrow. * **C. Penicillin:** Most commonly associated with **hypersensitivity reactions** (Type I IgE-mediated anaphylaxis). While high doses can rarely cause hemolytic anemia (Type II hypersensitivity), they do not cause red cell aplasia. * **D. Ciprofloxacin:** A fluoroquinolone known for causing **tendon rupture** (Achilles tendon), cartilage damage in children, and QT interval prolongation. It is not associated with bone marrow failure. **High-Yield Clinical Pearls for NEET-PG:** * **Gray Baby Syndrome:** Occurs in neonates due to deficient **glucuronyl transferase** enzyme, leading to chloramphenicol accumulation, cyanosis, and circulatory collapse. * **Mechanism of Resistance:** Primarily via the production of **chloramphenicol acetyltransferase**. * **Drug of Choice:** Though limited by toxicity, it remains a backup for enteric fever (Typhoid) and bacterial meningitis in patients with severe penicillin allergies.
Explanation: **Mechanism of Action: Acyclovir** **Correct Answer Explanation:** Acyclovir is a guanosine analogue that acts as a **prodrug**. Its selectivity and efficacy depend on a unique two-step activation process [1]: 1. **Initial Phosphorylation:** The drug is first converted to Acyclovir monophosphate by the **viral enzyme Thymidine Kinase (TK)** [1]. This step is crucial because host cell kinases do not efficiently phosphorylate acyclovir, ensuring the drug is only active in virus-infected cells [2]. 2. **Final Activation & Action:** Host cell kinases then convert the monophosphate into Acyclovir triphosphate. This active form acts as a potent **inhibitor of viral DNA polymerase** and also causes **DNA chain termination** when incorporated into the viral DNA strand [2]. **Why Other Options are Incorrect:** * **Option A:** While it eventually inhibits DNA polymerase, this option is incomplete. The "high-yield" distinction for Acyclovir is its absolute requirement for viral TK for activation [2]. * **Option B:** Acyclovir is a *substrate* for viral thymidine kinase, not an inhibitor [1]. * **Option C:** Reverse transcriptase is the target for antiretroviral drugs (like Zidovudine) used in HIV, not for anti-herpetic drugs. **NEET-PG High-Yield Pearls:** * **Spectrum:** Most active against **HSV-1**, followed by HSV-2 and VZV. It has minimal activity against CMV (which lacks TK). * **Resistance:** The most common mechanism of resistance is the **absence or mutation of viral Thymidine Kinase** [1]. * **Drug of Choice:** For Herpes Simplex Encephalitis and Genital Herpes. * **Side Effects:** When given IV, it can cause **Crystalline Nephropathy** (prevented by adequate hydration). * **Valacyclovir:** A prodrug of acyclovir with much higher oral bioavailability [2].
Explanation: ### Explanation **Correct Option: D (Proguanil)** Proguanil is considered safe for use during pregnancy, especially when combined with Chloroquine for malaria prophylaxis. It acts as a dihydrofolate reductase inhibitor. While it interferes with folate metabolism, clinical data has not shown an increased risk of congenital malformations or adverse pregnancy outcomes, provided it is administered with **folic acid supplementation** (5 mg daily) to counteract potential folate deficiency. **Analysis of Incorrect Options:** * **A. Atovaquone:** Generally avoided in pregnancy due to a lack of adequate human safety data. When combined with proguanil (Malarone), it is only recommended if the potential benefit justifies the unknown risk to the fetus. * **B. Pyrimethamine:** While used in some combinations (like Sulfadoxine-Pyrimethamine for IPTp), it is a potent folate antagonist. High doses are potentially teratogenic, particularly in the first trimester, making it less "safe" as a standalone choice compared to Proguanil. * **C. Primaquine:** **Strictly contraindicated** in pregnancy. It can cross the placenta and cause severe **hemolysis** in the fetus if the fetus is G6PD deficient. It is reserved for radical cure post-delivery. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Chloroquine remains the DOC for sensitive *P. falciparum* and *P. vivax* in all trimesters of pregnancy. * **Resistant Malaria:** For Chloroquine-resistant strains, **Quinine + Clindamycin** is the preferred regimen in the first trimester. **ACT (Artemisinin-based Combination Therapy)** is now recommended by the WHO for the second and third trimesters. * **Contraindicated Antimalarials:** Primaquine, Tetracycline, Doxycycline, and Halofantrine.
Explanation: **Explanation:** **Ivermectin** is the drug of choice for **Strongyloidiasis** (*Strongyloides stercoralis*). Unlike many other intestinal helminths, *Strongyloides* has a unique life cycle involving autoinfection, which can lead to life-threatening hyperinfection syndrome in immunocompromised patients. Ivermectin works by intensifying GABA-mediated neurotransmission and binding to glutamate-gated chloride channels, causing flaccid paralysis and death of the parasite. It is preferred over azoles due to its higher efficacy and shorter treatment duration (usually a single dose or two doses). **Analysis of Incorrect Options:** * **Albendazole:** While it has activity against *Strongyloides*, it is considered a second-line agent. It requires a longer course (3–7 days) and has lower cure rates compared to Ivermectin. It remains the drug of choice for Hydatid disease and Neurocysticercosis. * **Mebendazole:** It has poor systemic absorption and is generally ineffective against the tissue-migrating stages of *Strongyloides*. It is primarily used for pinworm, whipworm, and hookworm infections. * **Levamisole:** This agent acts as a nicotinic acetylcholine receptor agonist. While used for Ascariasis in the past, it is rarely used now due to toxicity (agranulocytosis) and is not effective for Strongyloidiasis. **High-Yield Clinical Pearls for NEET-PG:** * **DOC for Strongyloidiasis & Onchocerciasis (River Blindness):** Ivermectin. * **Mazzotti Reaction:** A severe immune response (fever, rash, hypotension) seen after treating Onchocerciasis with Ivermectin; managed with steroids. * **Hyperinfection Syndrome:** Always suspect in patients on steroids or with HTLV-1 infection presenting with *Strongyloides*. * **Ivermectin Safety:** Avoid in patients with a breached blood-brain barrier (e.g., meningitis) as it may cross and cause CNS depression.
Explanation: **Explanation:** The correct answer is **Pseudomembranous colitis**. **1. Why Option B is correct:** Vancomycin is a glycopeptide antibiotic that is poorly absorbed from the gastrointestinal tract when administered orally. While this makes it ineffective for systemic infections, it is highly advantageous for treating **Pseudomembranous colitis** (caused by *Clostridioides difficile*). Because it remains in the gut lumen, it reaches very high concentrations at the site of infection without causing systemic toxicity. It is currently considered a first-line agent for *C. difficile* infections (CDI). **2. Why other options are incorrect:** * **Option A (Hepatic encephalopathy):** This condition is typically managed with non-absorbable antibiotics like **Rifaximin** or **Neomycin** to reduce ammonia-producing bacteria in the gut. Oral vancomycin has no established role here. * **Option C (Staphylococcal food poisoning):** This is caused by the ingestion of preformed enterotoxins produced by *Staphylococcus aureus*, not an active infection. Treatment is supportive (rehydration); antibiotics are not indicated. **3. NEET-PG High-Yield Pearls:** * **Route of Administration:** For systemic infections (e.g., MRSA, Endocarditis), Vancomycin **must** be given intravenously. Oral vancomycin is *only* for local action in the gut. * **Mechanism of Action:** Inhibits cell wall synthesis by binding to the **D-Ala-D-Ala** terminus of nascent peptidoglycan pentapeptide. * **Adverse Effects:** Rapid IV infusion can cause **"Red Man Syndrome"** due to histamine release (prevented by slow infusion). It is also potentially nephrotoxic and ototoxic. * **Drug of Choice:** Oral Vancomycin or Fidaxomicin are preferred over Metronidazole for the initial episode of *C. difficile* infection.
Explanation: **Explanation:** The primary goal in treating tetanus (caused by *Clostridium tetani*) is to eradicate the vegetative bacteria to stop further toxin production. **Why Penicillin is Correct:** Historically and traditionally, **Penicillin G** (administered intravenously) is considered the drug of choice for tetanus. It is highly effective against the anaerobic, Gram-positive *C. tetani*. While some modern guidelines suggest Metronidazole as a preferred alternative due to theoretical concerns regarding Penicillin's GABA-antagonistic effects, most standard medical textbooks and NEET-PG examinations still recognize Penicillin as the classic primary treatment. **Analysis of Incorrect Options:** * **Metronidazole (C):** While frequently used in clinical practice today because it does not antagonize GABA (unlike Penicillin), it is often categorized as an alternative or "equally effective" option rather than the traditional primary answer in standard MCQ formats unless specified. * **Doxycycline (B):** This is a second-line agent used only in patients who are allergic to both Penicillin and Metronidazole. * **Clindamycin (A):** While it has anaerobic coverage, it is not a standard or first-line treatment for *C. tetani*. **High-Yield Clinical Pearls for NEET-PG:** 1. **Mechanism of Action:** *C. tetani* produces **Tetanospasmin**, which blocks the release of inhibitory neurotransmitters (**GABA and Glycine**) from Renshaw cells in the spinal cord, leading to spastic paralysis. 2. **Management Priority:** The most critical step in management is **neutralizing unbound toxin** using Human Tetanus Immunoglobulin (HTIG). 3. **Wound Debridement:** Essential to remove the anaerobic environment favoring bacterial growth. 4. **Supportive Care:** Use of Benzodiazepines (Diazepam) to control spasms and maintaining a quiet, dark environment to prevent reflex spasms.
Explanation: **Explanation:** The core concept tested here is the classification of cephalosporins and their specific spectrum of activity. Anti-pseudomonal activity is a characteristic feature of specific **3rd, 4th, and 5th generation** cephalosporins. **1. Why Cephadroxil is the correct answer:** Cephadroxil is a **1st generation cephalosporin**. First-generation agents (like Cephadroxil, Cephalexin, and Cefazolin) have excellent activity against Gram-positive cocci but very limited Gram-negative coverage. They have **no activity** against *Pseudomonas aeruginosa*. **2. Analysis of incorrect options (Anti-pseudomonal agents):** * **Ceftazidime (Option D):** A 3rd generation cephalosporin known for being the most potent agent against *Pseudomonas* in its class. * **Cefoperazone (Option C):** Another 3rd generation agent with anti-pseudomonal activity. It is unique because it is primarily excreted via bile and can cause a Disulfiram-like reaction. * **Cefepime (Option B):** A 4th generation cephalosporin. It possesses a broad spectrum, covering both Gram-positive organisms and resistant Gram-negative bacteria, including *Pseudomonas*. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Anti-pseudomonal Cephalosporins:** "Two **T**'s and two **P**'s" — Cef**t**azidime, Cef**t**olozane, Cefo**p**erazone, Cefe**p**ime. * **Ceftriaxone Exception:** While Ceftriaxone is a 3rd generation cephalosporin, it does **not** cover *Pseudomonas*. * **Cefiderocol:** A newer "Siderophore" cephalosporin (5th/6th gen) with excellent activity against multi-drug resistant *Pseudomonas*. * **Drug of Choice:** For *Pseudomonas* infections, Ceftazidime or Cefepime are often preferred over Cefoperazone due to better stability against beta-lactamases.
Explanation: **Explanation:** The core concept in G6PD deficiency is the inability of red blood cells (RBCs) to maintain adequate levels of **reduced glutathione**, which is essential for neutralizing oxidative stress. When exposed to oxidizing agents, hemoglobin denatures into **Heinz bodies**, leading to hemolysis. **1. Why Chloroquine is the Correct Answer:** Chloroquine is a 4-aminoquinoline used for malaria. Unlike its counterpart Primaquine, Chloroquine does not possess significant oxidizing potential. Extensive clinical data and pharmacological guidelines categorize Chloroquine as **safe** to administer in standard therapeutic doses to patients with G6PD deficiency without the risk of inducing acute hemolytic anemia. **2. Analysis of Incorrect Options:** * **Primaquine (Option D):** This is the classic "high-yield" trigger for hemolysis in G6PD deficiency. It is an 8-aminoquinoline that generates reactive oxygen species, causing severe oxidative damage to G6PD-deficient RBCs. * **Probenecid (Option B):** This uricosuric agent is historically listed as a drug to avoid or use with caution in G6PD deficiency, as it has been associated with hemolytic episodes in susceptible individuals. * **Aminopyrine (Option C):** This is an older analgesic/NSAID known to have oxidative properties that can trigger hemolysis in these patients. **3. NEET-PG High-Yield Pearls:** * **Safe Antimalarials:** Chloroquine, Quinine, and Proguanil. * **Unsafe Drugs (The "AAA" Mnemonic):** **A**ntimalarials (Primaquine), **A**ntibiotics (Sulfonamides, Nitrofurantoin, Dapsone), and **A**nalgesics (Aspirin - high doses, Phenazopyridine). * **Diagnostic Clue:** Look for "Heinz bodies" and "Bite cells" (degmacytes) on a peripheral smear post-exposure. * **Inheritance:** G6PD deficiency is an **X-linked recessive** disorder, providing protection against *Falciparum* malaria.
Explanation: ### Explanation **Correct Answer: C. Vancomycin** **1. Why Vancomycin is the Correct Choice:** Vancomycin is a glycopeptide antibiotic that inhibits cell wall synthesis by binding to the **D-Ala-D-Ala** terminus of nascent peptidoglycan chains. It remains the gold standard and **drug of choice (DOC)** for infections caused by Methicillin-Resistant *Staphylococcus aureus* (MRSA), which is the most common form of multidrug-resistant *S. aureus*. It is bactericidal against most Gram-positive organisms and is preferred for serious systemic infections like MRSA-induced endocarditis, osteomyelitis, and sepsis. **2. Why the Other Options are Incorrect:** * **A. Clindamycin:** While it can be used for minor skin and soft tissue infections caused by community-acquired MRSA, it is not the DOC for systemic multidrug-resistant strains. It also carries a high risk of *Clostridioides difficile* associated diarrhea. * **B. Streptogramins (e.g., Quinupristin/Dalfopristin):** These are reserved as "last-resort" drugs for Vancomycin-Resistant *S. aureus* (VRSA) or Vancomycin-Resistant *Enterococcus faecium* (VRE). They are not the first-line choice for standard multidrug-resistant *S. aureus*. * **D. Aztreonam:** This is a monobactam that is **only active against Gram-negative aerobic bacteria** (e.g., *Pseudomonas*). It has no activity against Gram-positive organisms like *S. aureus*. **3. High-Yield Clinical Pearls for NEET-PG:** * **Red Man Syndrome:** A common side effect of Vancomycin caused by rapid infusion leading to histamine release. It is prevented by slowing the infusion rate. * **Mechanism of Resistance:** VRSA occurs due to a change in the binding site from **D-Ala-D-Ala to D-Ala-D-Lac**. * **Alternative for MRSA:** If a patient is intolerant to Vancomycin or has VRSA, **Linezolid** (an oxazolidinone) or **Daptomycin** (a lipopeptide) are the next preferred options. * **Note:** Daptomycin cannot be used for MRSA pneumonia as it is inactivated by pulmonary surfactant.
Beta-Lactam Antibiotics
Practice Questions
Aminoglycosides
Practice Questions
Macrolides and Ketolides
Practice Questions
Tetracyclines
Practice Questions
Quinolones
Practice Questions
Sulfonamides and Trimethoprim
Practice Questions
Antimycobacterial Drugs
Practice Questions
Antifungal Agents
Practice Questions
Antiviral Drugs
Practice Questions
Antiparasitic Agents
Practice Questions
Principles of Antimicrobial Selection
Practice Questions
Antimicrobial Resistance
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free